Shares of Moderna ( MRNA) were up nearly 7% in recent trading, following a 12% jump Friday, after Bloomberg reported the ...

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near ...

Moderna stock climbed after the deadly hantavirus outbreak drew investors' attention to the company's ongoing infectious ...

Moderna (NASDAQ: MRNA) is best known for its coronavirus vaccine, a product that generated more than $18 billion in revenue at its peak in 2022 and helped drive the stock higher during the early days ...

Moderna posts a narrower-than-anticipated loss and sharply higher revenue for the first quarter.

Investors may be wondering whether Moderna's current share price reflects its true value, or if the market is still trying to figure the company out. The stock closed at US$48.69, with a 10.8% decline ...

Moderna has faced good and bad times in recent years. Most recently, the FDA refused to review Moderna’s flu candidate -- then reversed course. These 10 stocks could mint the next wave of millionaires ...

Moderna (MRNA) shares surge 8% after Q1 revenue hits $389M, tripling year-over-year and beating estimates on strong ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

By Julie Steenhuysen, Siddhi Mahatole and Mariam Sunny May 1 (Reuters) - Moderna surpassed Wall Street estimates for ...